Related Experiment Video
Updated: Jun 2, 2025

06:32
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
189
Unlocking Platelet Mechanisms through Multi-omics Integration: A Brief Review
Muhammad Mazhar Fareed1,2,3, Maryam Qasmi4, Zarmina Khan4
1Department of Computer Science, School of Science and Engineering, Università degli Studi di Verona, Verona, Italy.
Current Cardiology Reviews
|January 15, 2025
Summary
Platelets are key to blood clotting and vascular health. Advanced multi-omics methods reveal their complex roles in disease, aiding new diagnostics and therapies for cardiovascular conditions.
Area of Science:
- Hematology
- Proteomics
- Multi-omics
Background:
- Platelets are essential cell fragments for hemostasis and vascular integrity.
- Platelet abnormalities are implicated in bleeding disorders, thrombosis, and cardiovascular diseases.
- Understanding platelet function is critical for developing diagnostics and therapeutics.
Purpose of the Study:
- To explore the role of advanced proteomic and multi-omics techniques in understanding platelet biology.
- To investigate platelet activation pathways and posttranslational modifications.
- To enhance the identification of diagnostic markers and therapeutic targets for platelet-related disorders.
Main Methods:
- Utilized advanced proteomic techniques, including mass spectrometry-based proteomics and metabolomics.
- Employed multi-omics approaches to analyze the platelet proteome, lipidome, and metabolome.
- Integrated biochemical methods to investigate posttranslational modifications during platelet activation.
Main Results:
- Advanced proteomics provides deep insights into platelet functions beyond hemostasis, including inflammation and metastasis.
- Multi-omics analysis offers a holistic view of platelet biology, revealing complex mechanisms.
- The absence of a nucleus in platelets simplifies proteomic and metabolomic analyses.
Conclusions:
- Multi-omics technologies are crucial for elucidating platelet mechanisms in health and disease.
- These insights are vital for advancing therapeutic strategies and diagnostic tools for cardiovascular diseases.
- Further research integrating multi-omics holds significant promise for biomedical and clinical applications.
Keywords:
Plateletsbiochemical methodsbiomedicinecardiovascular diseasesmultiomicsrational drug design.More Related Videos
Related Concept Videos
Formation of the Platelet Plug
4.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.1K
Structure and Function of Platelets
971
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
971
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
464
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
464

